• Emergent Buys Adapt Pharma for $735M contractpharma
    August 30, 2018
    Emergent BioSolutions has entered into an agreement to acquire Adapt Pharma and its flagship product Narcan (naloxone HCl) Nasal Spray.......
PharmaSources Customer Service